Burning Rock Biotech Limited Net Change in Cash
Burning Rock Biotech Limited (BNR) reported Net Change in Cash of -CNY 41.07 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-28.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-04-28
CNY
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|
| 2025-12-31 | -41.07M CNY 20-F · filed 2026-04-28 | |
| 2024-12-31 | -93.05M CNY 20-F · filed 2026-04-28 | |
| 2023-12-31 | -310.05M CNY 20-F · filed 2026-04-28 | |
| 2022-12-31 | -513.84M CNY 20-F · filed 2025-04-29 | |
| 2022-06-30 | -286.06M CNY 6-K · filed 2022-11-07 | |
| 2021-12-31 | -486.09M CNY 20-F · filed 2024-04-29 | |
| 2021-06-30 | -41.94M CNY 6-K · filed 2022-11-07 | |
| 2020-12-31 | 1.83B CNY 20-F · filed 2023-04-20 | |
| 2019-12-31 | 2.91M CNY 20-F · filed 2022-04-29 | |
| 2018-12-31 | 40.55M CNY 20-F · filed 2021-03-23 |
USD
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|
| 2025-12-31 | -$5.87M 20-F · filed 2026-04-28 | |
| 2024-12-31 | -$12.75M 20-F · filed 2025-04-29 | |
| 2023-12-31 | -$43.67M 20-F · filed 2024-04-29 | |
| 2022-12-31 | -$74.50M 20-F · filed 2023-04-20 | |
| 2022-06-30 | -$42.71M 6-K · filed 2022-11-07 | |
| 2021-12-31 | -$76.28M 20-F · filed 2022-04-29 | |
| 2020-12-31 | $279.99M 20-F · filed 2021-03-23 |